Additionally, the blocking of MTH1 function contributes to epithelial-mesenchymal transition and cell proliferation suppression, revealing MTH1 as a promising therapeutic target, particularly in NSCLC cases 24, 25. The gene discussed is NUDT1; the disease is non-small cell lung carcinoma.